Your browser doesn't support javascript.
loading
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy.
Siolas, Despina; Vucic, Emily; Kurz, Emma; Hajdu, Cristina; Bar-Sagi, Dafna.
Affiliation
  • Siolas D; Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: despina.siolas@nyulangone.org.
  • Vucic E; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.
  • Kurz E; Molecular Oncology and Tumor Immunology Training Program, NYU Grossman School of Medicine, New York, NY, USA.
  • Hajdu C; Department of Pathology, NYU Langone Health, New York, NY, USA.
  • Bar-Sagi D; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: dafna.bar-sagi@nyulangone.org.
Cell Rep ; 36(8): 109578, 2021 08 24.
Article in En | MEDLINE | ID: mdl-34433022

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Tumor Suppressor Protein p53 / Neutrophil Infiltration / Carcinoma, Pancreatic Ductal / Gain of Function Mutation / Immunotherapy / Neutrophils Limits: Animals Language: En Journal: Cell Rep Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Tumor Suppressor Protein p53 / Neutrophil Infiltration / Carcinoma, Pancreatic Ductal / Gain of Function Mutation / Immunotherapy / Neutrophils Limits: Animals Language: En Journal: Cell Rep Year: 2021 Type: Article